Mina Hassan‐Zahraee

Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial

Séverine Vermeire, William J. Sandborn, Silvio Danese et al. · The Lancet · 2017 · 197 citations

Inflammation, Autoimmune Disease, Mucosal Immunology +9

The Delayed Hypersensitivity Response and Host Resistance in Surgical Patients

Nicolas V. Christou, Jonathan L. Meakins, Julius Gordon et al. · Annals of Surgery · 1995 · 139 citations · Full text

Phase II evaluation of anti-MAdCAM antibody PF-00547659 in the treatment of Crohn’s disease: report of the OPERA study

William J. Sandborn, Scott D. Lee, Dino Tarabar et al. · Gut · 2017 · 107 citations · Full text

Heat Shock Protein-Mediated Cross-Presentation of Exogenous HIV Antigen on HLA Class I and Class II

Devi SenGupta, Philip J. Norris, Todd J. Suscovich et al. · The Journal of Immunology · 2004 · 84 citations · Full text

Oral Ritlecitinib and Brepocitinib for Moderate-to-Severe Ulcerative Colitis: Results From a Randomized, Phase 2b Study

William J. Sandborn, Silvio Danese, Jarosław Leszczyszyn et al. · Clinical Gastroenterology and Hepatology · 2023 · 82 citations

Gastrointestinal Pharmacology, Phase 2B, Moderate-to-severe Ulcerative Colitis +5